245 related articles for article (PubMed ID: 31467281)
41. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics".
Pons-Estel BA; Catoggio LJ; Cardiel MH; Soriano ER; Gentiletti S; Villa AR; Abadi I; Caeiro F; Alvarellos A; Alarcón-Segovia D;
Medicine (Baltimore); 2004 Jan; 83(1):1-17. PubMed ID: 14747764
[TBL] [Abstract][Full Text] [Related]
42. Validation of the 2019 European League Against Rheumatism/American College of Rheumatology Criteria Compared to the 1997 American College of Rheumatology Criteria and the 2012 Systemic Lupus International Collaborating Clinics Criteria in Pediatric Systemic Lupus Erythematosus.
Ma M; Hui-Yuen JS; Cerise JE; Iqbal S; Eberhard BA
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1597-1601. PubMed ID: 31478595
[TBL] [Abstract][Full Text] [Related]
43. Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
Aberle T; Bourn RL; Munroe ME; Chen H; Roberts VC; Guthridge JM; Bean K; Robertson JM; Sivils KL; Rasmussen A; Liles M; Merrill JT; Harley JB; Olsen NJ; Karp DR; James JA
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1780-1788. PubMed ID: 28118528
[TBL] [Abstract][Full Text] [Related]
44. Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in a multiethnic Malaysian cohort.
Selvananda S; Kan SL
Int J Rheum Dis; 2022 Feb; 25(2):131-139. PubMed ID: 34939743
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients.
Coit P; Jeffries M; Altorok N; Dozmorov MG; Koelsch KA; Wren JD; Merrill JT; McCune WJ; Sawalha AH
J Autoimmun; 2013 Jun; 43():78-84. PubMed ID: 23623029
[TBL] [Abstract][Full Text] [Related]
46. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
[TBL] [Abstract][Full Text] [Related]
47. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.
Andrade RM; Alarcón GS; Fernández M; Apte M; Vilá LM; Reveille JD;
Arthritis Rheum; 2007 Feb; 56(2):622-30. PubMed ID: 17265497
[TBL] [Abstract][Full Text] [Related]
48. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
Alarcón GS; McGwin G; Bartolucci AA; Roseman J; Lisse J; Fessler BJ; Bastian HM; Friedman AW; Reveille JD;
Arthritis Rheum; 2001 Dec; 44(12):2797-806. PubMed ID: 11762940
[TBL] [Abstract][Full Text] [Related]
49. Single Nucleotide Polymorphisms in
Qi YY; Zhai YL; Liu XR; Zhang XX; Zhao YF; Ning XH; Zhao ZZ
J Immunol Res; 2020; 2020():7285747. PubMed ID: 32566688
[TBL] [Abstract][Full Text] [Related]
50. Genetic load in incomplete lupus erythematosus.
Slief M; Kheir JM; Smith M; Mowery C; Macwana S; DeJager W; Wagner CA; Aberle T; James JA; Guthridge JM
Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36599633
[TBL] [Abstract][Full Text] [Related]
51. Epione application: An integrated web‑toolkit of clinical genomics and personalized medicine in systemic lupus erythematosus.
Papageorgiou L; Alkenaris H; Zervou MI; Vlachakis D; Matalliotakis I; Spandidos DA; Bertsias G; Goulielmos GN; Eliopoulos E
Int J Mol Med; 2022 Jan; 49(1):. PubMed ID: 34791504
[TBL] [Abstract][Full Text] [Related]
52. Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
A Mohammed RH; Lotfy Fayed H; Ibrahim Emara N
Lupus; 2022 Apr; 31(5):628-636. PubMed ID: 35306918
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations.
da Silva Fonseca AM; de Azevedo Silva J; Pancotto JA; Donadi EA; Segat L; Crovella S; Sandrin-Garcia P
Gene; 2013 Sep; 527(2):435-9. PubMed ID: 23860322
[TBL] [Abstract][Full Text] [Related]
54. Epigenetics and Systemic Lupus Erythematosus: Unmet Needs.
Meroni PL; Penatti AE
Clin Rev Allergy Immunol; 2016 Jun; 50(3):367-76. PubMed ID: 26206675
[TBL] [Abstract][Full Text] [Related]
55. Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature.
Shobha V; Mohan A; Malini AV; Chopra P; Karunanithi P; Subramani Thulasingam S; Selvam S; Deyati A; Srivastava R; Basavanthappa S; Lemos N; Sunitha SM; Mazumder Tagore D; Anand A; Pant S; Jayaswal V; Ramarao M; Dudhgaonkar S
Lupus; 2021 Apr; 30(5):762-774. PubMed ID: 33497307
[TBL] [Abstract][Full Text] [Related]
56. APO1/F AS promoter polymorphism in systemic lupus erythematosus (SLE): significance in clinical expression of the disease.
Pradhan VD
J Assoc Physicians India; 2012 Sep; 60():34-7. PubMed ID: 23547411
[TBL] [Abstract][Full Text] [Related]
57. Genomics of Systemic Lupus Erythematosus: Insights Gained by Studying Monogenic Young-Onset Systemic Lupus Erythematosus.
Hiraki LT; Silverman ED
Rheum Dis Clin North Am; 2017 Aug; 43(3):415-434. PubMed ID: 28711143
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.
Aterido A; Julià A; Carreira P; Blanco R; López-Longo JJ; Venegas JJP; Olivé À; Andreu JL; Aguirre-Zamorano MÁ; Vela P; Nolla JM; Marenco-de la Fuente JL; Zea A; Pego JM; Freire M; Díez E; López-Lasanta M; López-Corbeto M; Palau N; Tortosa R; Gelpí JL; Absher D; Myers RM; Fernández-Nebro A; Marsal S
Arthritis Res Ther; 2017 Jun; 19(1):138. PubMed ID: 28619073
[TBL] [Abstract][Full Text] [Related]
59. Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective.
Pons-Estel GJ; Ugarte-Gil MF; Harvey GB; Wojdyla D; Quintana R; Saurit V; Soriano ER; Bonfa E; Massardo L; Cardiel M; Vila LM; Griffin R; Pons-Estel BA; Alarcón GS;
RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958284
[TBL] [Abstract][Full Text] [Related]
60. Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up.
Bortoluzzi A; Furini F; Campanaro F; Govoni M
Lupus; 2017 May; 26(6):616-622. PubMed ID: 27703051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
